Cargando…
Functionally Improved Mesenchymal Stem Cells to Better Treat Myocardial Infarction
Myocardial infarction (MI) is one of the leading causes of death worldwide. Mesenchymal stem cell (MSC) transplantation is considered a promising approach and has made significant progress in preclinical studies and clinical trials for treating MI. However, hurdles including poor survival, retention...
Autores principales: | Chen, Zhi, Chen, Long, Zeng, Chunyu, Wang, Wei Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286742/ https://www.ncbi.nlm.nih.gov/pubmed/30622568 http://dx.doi.org/10.1155/2018/7045245 |
Ejemplares similares
-
Over-expression of HO-1 on mesenchymal stem cells promotes angiogenesis and improves myocardial function in infarcted myocardium
por: Zeng, Bin, et al.
Publicado: (2010) -
Priming mesenchymal stem cells boosts stem cell therapy to treat myocardial infarction
por: Carvalho, Juliana L, et al.
Publicado: (2013) -
How to Improve the Survival of Transplanted Mesenchymal Stem Cell in Ischemic Heart?
por: Li, Liangpeng, et al.
Publicado: (2016) -
Drug-based mobilisation of mesenchymal stem/stromal cells improves cardiac function post myocardial infarction
por: Todorova, Veneta B., et al.
Publicado: (2022) -
In vivo imaging to monitor differentiation and therapeutic effects of transplanted mesenchymal stem cells in myocardial infarction
por: Pei, Zhijun, et al.
Publicado: (2017)